Tocqueville Asset Management L.P. Takes $843,000 Position in Corteva, Inc. $CTVA

Tocqueville Asset Management L.P. acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 9,955 shares of the company’s stock, valued at approximately $843,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CTVA. BlackRock Inc. bought a new stake in Corteva in the 2nd quarter worth approximately $4,560,180,000. Harris Associates L P lifted its holdings in shares of Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the period. Norges Bank purchased a new position in shares of Corteva in the 4th quarter worth $504,001,000. Royal Bank of Canada grew its holdings in shares of Corteva by 202.1% in the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after acquiring an additional 4,989,371 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in Corteva during the second quarter valued at $392,447,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 1.1%

Shares of NYSE:CTVA opened at $79.46 on Friday. The stock has a 50 day moving average of $82.01 and a 200 day moving average of $80.20. The company has a market cap of $53.02 billion, a PE ratio of 52.62, a price-to-earnings-growth ratio of 2.41 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm’s revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is 47.68%.

Wall Street Analyst Weigh In

CTVA has been the topic of a number of recent research reports. Oppenheimer increased their target price on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. UBS Group reduced their price target on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research report on Tuesday. Morgan Stanley increased their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Jefferies Financial Group boosted their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Finally, Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.